- Home
- JAKK vs VNDA Comparison
JAKK vs VNDA Comparison
Compare JAKK & VNDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JAKK
- VNDA
- Stock Information
- Founded
- JAKK 1995
- VNDA 2002
- Country
- JAKK United States
- VNDA United States
- Employees
- JAKK N/A
- VNDA N/A
- Industry
- JAKK Recreational Games/Products/Toys
- VNDA Biotechnology: Pharmaceutical Preparations
- Sector
- JAKK Consumer Discretionary
- VNDA Health Care
- Exchange
- JAKK Nasdaq
- VNDA Nasdaq
- Market Cap
- JAKK 231.8M
- VNDA 249.4M
- IPO Year
- JAKK 1996
- VNDA 2006
- Fundamental
- Price
- JAKK $18.21
- VNDA $4.52
- Analyst Decision
- JAKK Strong Buy
- VNDA Strong Buy
- Analyst Count
- JAKK 4
- VNDA 2
- Target Price
- JAKK $40.25
- VNDA $16.50
- AVG Volume (30 Days)
- JAKK 77.9K
- VNDA 346.2K
- Earning Date
- JAKK 10-29-2025
- VNDA 11-05-2025
- Dividend Yield
- JAKK 5.53%
- VNDA N/A
- EPS Growth
- JAKK 25.15
- VNDA N/A
- EPS
- JAKK 3.34
- VNDA N/A
- Revenue
- JAKK $684,694,000.00
- VNDA $203,467,000.00
- Revenue This Year
- JAKK N/A
- VNDA $15.45
- Revenue Next Year
- JAKK $4.01
- VNDA $37.82
- P/E Ratio
- JAKK $5.40
- VNDA N/A
- Revenue Growth
- JAKK 1.31
- VNDA 11.78
- 52 Week Low
- JAKK $16.24
- VNDA $3.81
- 52 Week High
- JAKK $35.79
- VNDA $5.55
- Technical
- Relative Strength Index (RSI)
- JAKK 55.91
- VNDA 49.04
- Support Level
- JAKK $17.91
- VNDA $4.36
- Resistance Level
- JAKK $18.88
- VNDA $4.64
- Average True Range (ATR)
- JAKK 0.41
- VNDA 0.15
- MACD
- JAKK 0.09
- VNDA -0.02
- Stochastic Oscillator
- JAKK 57.76
- VNDA 27.68
About JAKK JAKKS Pacific Inc.
Jakks Pacific Inc is a multi-product line, multi-brand toy company that designs, produces, markets, sells and distributes toys and related kid-targeted consumer products, inclusive of kids indoor and outdoor furniture, costumes and various product lines in the sporting goods and home furnishings space. Its products offering include Traditional toys and electronics such as Action figures, Toy vehicles, Dolls and accessories, Ride-on toys, Toys for pets, and others. The company's products have been divided into two segments: (i) Toys/Consumer Products and (ii) Costumes.
About VNDA Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products; HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS); Fanapt for the treatment of schizophrenia; and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from the Fanapt product sales. Geographically, the company sells its product predominantly in the United States, and also in Israel, Europe, and Canada.